<unk>  is an aromatase inhibitor that is FDA approved for the treatment of suppression of adrenal function in selected patients with Cushing’s syndrome.   Common adverse reactions include drowsiness , morbilliform skin rash , nausea and anorexia , and dizziness.
Aminoglutethimide
Ethinylestradiol
Fluoxymesterone
Hydroxyprogesterone caproate
Desoxymethyltestosterone
Mifepristone
Leuprolide
Formestane